, Tracking Stock Market Picks
Enter Symbol:
Sarepta Therapeutics Inc (SRPT) [hlAlert]

down 1.68 %

Sarepta Therapeutics Inc (SRPT) rated Buy with price target $51 by Stifel

Posted on: Friday,  Sep 6, 2013  8:25 AM ET by Stifel

Stifel rated Buy Sarepta Therapeutics Inc (NASDAQ: SRPT) on 09/06/2013, when the stock price was $36.85. Since
then, Sarepta Therapeutics Inc has lost 1.68% as of 01/19/2016's recent price of $36.23.
If you would have followed this Stifel's recommendation on SRPT, you would have lost 1.68% of your investment in 865 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/6/2013 8:25 AM Buy
36.85 51.00
as of 12/13/2013
1 Week up  9.18 %
1 Month up  53.06 %
3 Months down  -46.97 %
1 YTD down  -46.45 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy